Heidi Fields - 30 Jul 2021 Form 4 Insider Report for Icosavax, Inc.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 30 Jul 2021
Net transaction value: +$131,250
SEC form: 4
Accepted by SEC: 02 Aug 2021, 21:25:47 UTC
Prior SEC filing: 28 Jul 2021
Next SEC filing: 21 Mar 2022
Source filing: View source filing
Reporting owner signature: /s/ Thomas Russo, Attorney-in-Fact

Key filing fact

Heidi Fields filed Form 4 for Icosavax, Inc. on 02 Aug 2021.

Key facts

This page summarizes Heidi Fields's Form 4 filing for Icosavax, Inc..
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 Aug 2021, 21:25.

Change

Previous filing in this sequence was filed on 28 Jul 2021.
Current net transaction value: +$131,250.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ICVX transaction

Common Stock

Award

Transaction value: $131,250
Shares: +8,750
Change %
Price: $15.00
Shares after: 8,750
Date: 30 Jul 2021
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents restricted stock units ("RSUs") granted on July 30, 2021, 1/3 of the total number of RSUs granted vest on each of the first three anniversaries of May 29, 2021, the vesting commencement date, subject to the reporting person's continued service on the applicable vesting date. Vesting of the RSUs shall accelerate upon a Change of Control (as defined in the Icosavax, Inc. 2021 Incentive Award Plan). Each RSU represents a contingent right to receive one share of common stock of the Issuer.